Skip to main content
رجوع
RCDTF logo

Recordati Industria Chimica e Farmaceutica S.p.A.

جودة البيانات: 100%
ذروة بيع
RCDTF
OTC Healthcare Drug Manufacturers - General
KWD 56.95
KWD 0.00 (0.00%)
القيمة السوقية: 11.61B
نطاق اليوم
KWD 51.60 KWD 56.95
نطاق 52 أسبوعًا
KWD 49.00 KWD 65.44
حجم التداول
2
متوسط 50 يوم / 200 يوم
KWD 62.38 / KWD 64.68
الإغلاق السابق
KWD 56.95

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 27.9 0.3
P/B 6.2 3.0
ROE % 23.4 3.7
Net Margin % 17.8 3.8
Rev Growth 5Y % 12.8 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 5.38
KWD 5.21 – KWD 5.51
3.65B 1
FY2029 KWD 4.55
KWD 4.41 – KWD 4.67
3.48B 1
FY2028 KWD 4.06
KWD 3.93 – KWD 4.16
3.18B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-17 KWD 0.86 KWD 0.86 +0.4%
2025-11-11 N/A KWD 0.93
2025-07-30 KWD 0.90 KWD 0.82 -9.0%
2025-05-08 N/A KWD 0.88
2025-02-13 N/A KWD 0.39
2024-11-08 KWD 0.76 KWD 0.74 -2.2%
2024-07-30 KWD 0.70 KWD 0.70 +0.6%
2024-05-09 KWD 0.75 KWD 0.85 +14.1%

Dividend History

Yield

0.02%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Nov 25, 2025 Nov 26, 2025 KWD 0.73 2.31%
May 20, 2025 May 21, 2025 KWD 0.75 2.66%
Nov 19, 2024 Nov 20, 2024 KWD 0.64 2.76%
May 20, 2024 May 22, 2024 KWD 0.68 2.73%
Nov 20, 2023 Nov 22, 2023 KWD 0.62 2.98%
May 22, 2023 May 24, 2023 KWD 0.65 3.29%
Nov 21, 2022 Nov 23, 2022 KWD 0.56 3.65%
May 23, 2022 May 25, 2022 KWD 0.61 3.07%
Nov 22, 2021 Nov 24, 2021 KWD 0.60 1.98%
May 24, 2021 May 26, 2021 KWD 0.67 2.29%
Nov 23, 2020 Nov 25, 2020 KWD 0.59 2.18%
May 18, 2020 May 20, 2020 KWD 0.57 2.47%
Nov 18, 2019 Nov 20, 2019 KWD 0.53 2.70%
Apr 23, 2019 Apr 25, 2019 KWD 0.53 3.11%
Nov 19, 2018 Nov 21, 2018 KWD 0.52 2.76%
Apr 23, 2018 Apr 25, 2018 KWD 0.53 2.37%
Nov 20, 2017 Nov 22, 2017 KWD 0.49 2.15%
Apr 24, 2017 Apr 26, 2017 KWD 0.38 2.59%
Nov 21, 2016 Nov 23, 2016 KWD 0.37 2.40%
Apr 18, 2016 Apr 20, 2016 KWD 0.34 2.94%

النقاط الرئيسية

Revenue grew 12.75% annually over 5 years — strong growth
ROE of 23.38% indicates high profitability
Net margin of 17.79% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -281.24M
Capital intensive — 36.35% of revenue goes to capex

النمو

Revenue Growth (5Y)
12.75%
Revenue (1Y)12.45%
Earnings (1Y)7.01%
FCF Growth (3Y)N/A

الجودة

Return on Equity
23.38%
ROIC25.22%
Net Margin17.79%
Op. Margin27.28%

الأمان

Debt / Equity
0.01
Current Ratio1.61
Interest Coverage7.83

التقييم

P/E Ratio
27.87
Forward P/EN/A
P/B Ratio6.19
EV/EBITDA17.70
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 12.45% Revenue Growth (3Y) 12.40%
Earnings Growth (1Y) 7.01% Earnings Growth (3Y) 15.48%
Revenue Growth (5Y) 12.75% Earnings Growth (5Y) 4.08%
Profitability
Revenue (TTM) 2.34B Net Income (TTM) 416.51M
ROE 23.38% ROA 8.11%
Gross Margin 68.34% Operating Margin 27.28%
Net Margin 17.79% Free Cash Flow (TTM) -281.24M
ROIC 25.22% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 1.61
Interest Coverage 7.83
Dividends
Dividend Yield 0.02% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 27.87 Forward P/E N/A
P/B Ratio 6.19 P/S Ratio 4.96
PEG Ratio 3.09 Forward PEG N/A
EV/EBITDA 17.70 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2.42%
Market Cap 11.61B Enterprise Value 11.31B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2.34B 2.08B 1.85B 1.58B 1.45B
Net Income 416.51M 389.21M 312.34M 385.97M 354.98M
EPS (Diluted) 1.99 1.86 1.49 1.85 1.70
Gross Profit 1.60B 1.48B 1.29B 1.15B 1.04B
Operating Income 638.86M 558.01M 437.33M 490.19M 469.02M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 5.13B 4.21B 4.00B 2.82B 2.71B
Total Liabilities 3.26B 2.52B 2.45B 1.43B 1.44B
Shareholders' Equity 1.88B 1.69B 1.55B 1.38B 1.28B
Total Debt 22.85M 99.93M 1.72B 992.19M 1.06B
Cash & Equivalents 322.42M 221.81M 284.73M 244.58M 188.23M
Current Assets 1.49B 1.20B 1.19B 850.10M 772.95M
Current Liabilities 929.06M 1.00B 923.74M 626.42M 578.46M